🔬 FDA-Approved AI

Today we review a study published in JACR that predicts 350 new AI health products by 2035

Happy Wednesday!

It takes approximately six years for AI innovations to transition from the funding stage to FDA clearance. It is now estimated we will see 350 new FDA-approved AI health products by 2035.

Let’s Review 👇

Emoji Increasing GIF by emoji® - The Iconic Brand

A recent study predicts that AI medical products in the United States will expand fivefold by 2035.

The researchers analyzed the connection between AI venture capital funding and the influx of new AI products. They found that funding for AI applications has grown significantly, with medical imaging accounting for 85% of digital health venture capital funding.

The study predicts that by 2028, 147 new AI products will be introduced, with the majority likely being related to imaging. By 2035, the study projects there will be 350 new AI products.

If funding continues on its current trajectory, it is expected to reach $30.8 billion in 2029, leading to the development of FDA-approved AI products.

The study concludes that AI will continue to grow and change the healthcare field vastly over the next decade. (Read More)

YOUR DAILY TOOL đź› 

Dewey - is an AI tool that helps you cultivate new habits through SMS text message reminders.

YOUR DAILY JOKE 🤣

âťť

Why did the puppy do so well at school?

It was the teacher’s pet!

Generated by ChatGPT

  • Jenni - Supercharge your next research paper using AI.

    *(Visit)

  • Buoy Health - An AI-based symptom checker that uses algorithms to diagnose and treat illness.

    (Visit)

  • Deepcell - Uses AI and microfluidics to develop technology for single-cell morphology.

    (Visit)

  • Iodine - Uses AI-powered and machine-learning solutions to improve patient care and increase response rates.

    (Visit)

  • Tempus - Uses AI to sift through the world’s largest collection of clinical and molecular data to personalize healthcare treatments.

    (Visit)

*Sponsored Partner

That’s all for today!

As always, if you have feedback, new information, or want to collaborate please let me know.

P.S. Connect with me on LinkedIn.

Reply

or to participate.